# FDA recall D-0419-2020

> **Altaire Pharmaceuticals, Inc.** · Class II · drug recall initiated 2019-07-02.

## Product

Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 NDC 59390-217-02

## Reason for recall

Lack of Assurance of Sterility

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-0419-2020
- **Recalling firm:** Altaire Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2019-07-02
- **Report date:** 2019-11-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Aquebogue, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0419-2020

## Citation

> AI Analytics. FDA recall D-0419-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0419-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*